Currently, immunohistochemical evaluation of MDM2 and CDK4 may help screen for 12q13-15 amplification.[15] In our case, both the immunohistochemical expression and the amplification of the MDM2 gene confirmed the diagnosis of dedifferentiated liposarcoma. The gene discussed is CDK4; the disease is liposarcoma.